Jim Cornall

biotech

Mechanism ‘opens new era’ for targeted cancer therapy

biotech

myTomorrows and Rare Disease Research partner to improve access to rare disease clinical trials

biotech

Resolve Therapeutics and Institut Pasteur collaborate to identify cell-free RNA triggers in autoimmunity

biotech

Stem cell therapy for type 1 diabetes

biotech

New technique maps cancer drug uptake inside living cells

biotech

Group develops inhaled therapy to reduce lung damage from severe infections

biotech

Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics

biotech

CRISPR variant selectively targets tumour DNA